Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |